Ahlam Qerqez

Title: Ahlam Qerqez: Innovator in Antibody Research

Introduction

Ahlam Qerqez is a notable inventor based in Austin, TX (US). He has made significant contributions to the field of antibody research, particularly in the development of antibodies that target myocilin. With a total of 2 patents, Qerqez's work is paving the way for advancements in medical diagnostics and treatment.

Latest Patents

One of Ahlam Qerqez's latest patents is titled "ANTI-MYOCILIN OLF ANTIBODIES AND METHODS OF USE THEREOF." This patent focuses on antibodies that bind to natively folded myocilin. The invention includes myocilin-binding agents, such as antibodies and antigen-binding fragments, as well as fusion proteins that specifically bind to the coiled-coil domain of myocilin. Importantly, these agents do not bind to misfolded myocilin, making them useful for the detection and extraction of natively folded myocilin from various samples.

Career Highlights

Ahlam Qerqez is affiliated with the Georgia Tech Research Corporation, where he continues to innovate and contribute to research in his field. His work is characterized by a commitment to advancing scientific knowledge and improving healthcare outcomes.

Collaborations

Ahlam collaborates with Raquel L Lieberman, a fellow researcher who brings her expertise to their joint projects. Their partnership exemplifies the collaborative spirit that drives innovation in research.

Conclusion

Ahlam Qerqez is a distinguished inventor whose work in antibody research is making a significant impact. His patents and collaborations highlight his dedication to advancing medical science and improving patient care.